Immunocore Holdings Ltd Cash Flow Quality Index

Latest as of March 2026: -1.06x

Immunocore Holdings Ltd cash flow quality index. Immunocore Holdings Ltd (IMCR) has a Cash Flow Quality Index of -1.06x as of March 2026. Operating cash flow of $-13.75 Million is below net income of $12.95 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Immunocore Holdings Ltd to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.06x
Operating CF / Net Income

Operating Cash Flow

$-13.75 Million
USD

Net Income

$12.95 Million
USD

Data as of

Mar 2026
Most recent filing

Cash Flow Quality Index of Immunocore Holdings Ltd (2015–2015)

Cash flow quality index of Immunocore Holdings Ltd from 2015 to 2015. Historical Cash Flow Quality Index for Immunocore Holdings Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Immunocore Holdings Ltd balance sheet independence to measure how much of total assets are equity-financed.

Immunocore Holdings Ltd Cash Flow Quality Index by Year (2015–2015)

Immunocore Holdings Ltd cash flow quality index by year from 2015 to 2015. Year-by-year earnings quality comparison for Immunocore Holdings Ltd. For the full cash flow conversion analysis, see cash flow conversion of Immunocore Holdings Ltd.

Year Quality Index Operating CF (USD) Net Income YoY Change
2015 -1.33x $-17.92 Million $13.45 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.